Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Sets up a governance structure and implements guidelines for joint manufacturing services to support clients.
April 28, 2021
By: Kristin Brooks
Managing Editor, Contract Pharma
Rentschler Biopharma and Vetter, two global CDMOs, have advanced their strategic collaboration, establishing a framework for their alliance and set up a governance structure, as well as implemented guidelines for their joint approach across functions. Along with starting their first joint client projects, they are also working closely on existing projects and related topics. The collaboration initiated in mid-2020, aims to create long-term value through the alignment of manufacturing approaches that enable clients to bring their products to patients more easily and faster. The companies are mutually enhancing their services by offering complementary skills and experience along the biopharmaceutical value chain. The established framework consists of an overall collaboration agreement that regulates the intended contributions of both parties to ultimately generate added value for clients. Further operational agreements and guidelines between various departments including Quality, Development Service and Logistics have been implemented. These cover key standards for joint approaches as well as core inputs and processes across both organizations to align interfaces and optimize services for the client’s convenience and long-term planning. The alignment of departments also includes the companies’ global business development teams. The companies have also defined the target markets for their collaboration, focusing on Europe, U.S. and the Asia-Pacific, as well as emerging markets. “The formation of the mutual agreements and alignment on a client approach were foundational steps that both Vetter and Rentschler Biopharma identified early in our exploration of this strategic alliance,” said Vetter Managing Director Peter Soelkner. “We look forward to the new progress that this step will facilitate.” “We are very interested to see how the experience gained in these initial projects will further enhance our strategic alliance,” said Dr. Frank Mathias, CEO of Rentschler Biopharma. “These client engagements will provide valuable insights for our teams to leverage in refining the alignment of our processes and approaches.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !